Viewing Study NCT01046461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-31 @ 11:37 AM
Study NCT ID: NCT01046461
Status: UNKNOWN
Last Update Posted: 2012-02-17
First Post: 2010-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
Sponsor: Hallym University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumour View
None Postoperative Nausea and Vomiting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ramosetron View
None aprepitant View
None dexamethasone View
None cancer View
None chemotherapy View
None antiemetics View
None cisplatin View
None nausea View
None vomiting View
None high dose cisplatin View